Nixon Peabody Trust CO Cortexyme, Inc. Transaction History
Nixon Peabody Trust CO
- $1.18 Billion
- Q3 2024
A detailed history of Nixon Peabody Trust CO transactions in Cortexyme, Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 11,126 shares of CRTX stock, worth $14,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,126
Previous 11,126
-0.0%
Holding current value
$14,352
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRTX
# of Institutions
39Shares Held
5.21MCall Options Held
90.8KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.2MShares$1.55 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA826KShares$1.07 Million0.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny523KShares$674,1230.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA383KShares$493,9170.23% of portfolio
-
Black Rock Inc. New York, NY355KShares$457,6760.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M